Herrmann E - Search Results

1

Association of HCV-related mixed cryoglobulinemia with specific mutational pattern of the HCV E2 protein and CD81 expression on peripheral B lymphocytes.

Hofmann WP, Herrmann E, Kronenberger B, Merkwirth C, Welsch C, Lengauer T, Zeuzem S, Sarrazin C. Hofmann WP, et al. Among authors: herrmann e. Blood. 2004 Aug 15;104(4):1228-9. doi: 10.1182/blood-2004-02-0644. Blood. 2004. PMID: 15294858 Free article. No abstract available.

2

Hepatitis C virus kinetics.

Herrmann E, Neumann AU, Schmidt JM, Zeuzem S. Herrmann E, et al. Antivir Ther. 2000 Jun;5(2):85-90. Antivir Ther. 2000. PMID: 10971860 Review.

3

Quasispecies heterogeneity of the carboxy-terminal part of the E2 gene including the PePHD and sensitivity of hepatitis C virus 1b isolates to antiviral therapy.

Sarrazin C, Bruckner M, Herrmann E, Rüster B, Bruch K, Roth WK, Zeuzem S. Sarrazin C, et al. Among authors: herrmann e. Virology. 2001 Oct 10;289(1):150-63. doi: 10.1006/viro.2001.1092. Virology. 2001. PMID: 11601926 Free article.

4

First-phase parameters in hepatitis C viral kinetics.

Zeuzem S, Herrmann E. Zeuzem S, et al. Among authors: herrmann e. J Viral Hepat. 2002 Sep;9(5):332-3. doi: 10.1046/j.1365-2893.2002.00375.x. J Viral Hepat. 2002. PMID: 12225326 No abstract available.

5

Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses.

Sarrazin C, Herrmann E, Bruch K, Zeuzem S. Sarrazin C, et al. Among authors: herrmann e. J Virol. 2002 Nov;76(21):11079-90. doi: 10.1128/jvi.76.21.11079-11090.2002. J Virol. 2002. PMID: 12368350 Free PMC article.

6

Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy.

Berg T, Sarrazin C, Herrmann E, Hinrichsen H, Gerlach T, Zachoval R, Wiedenmann B, Hopf U, Zeuzem S. Berg T, et al. Among authors: herrmann e. Hepatology. 2003 Mar;37(3):600-9. doi: 10.1053/jhep.2003.50106. Hepatology. 2003. PMID: 12601358

7

Hepatitis C viral kinetic models.

Herrmann E, Zeuzem S. Herrmann E, et al. Cell Death Differ. 2003 Jan;10 Suppl 1:S7-8. doi: 10.1038/sj.cdd.4401118. Cell Death Differ. 2003. PMID: 12655337 Review. No abstract available.

8

Response predictors and results of a long-term treatment with lamivudine in patients with chronic hepatitis B.

Mihm U, Sarrazin C, Herrmann E, Teuber G, von Wagner M, Kronenberger B, Zeuzem S. Mihm U, et al. Among authors: herrmann e. Z Gastroenterol. 2003 Mar;41(3):249-54. doi: 10.1055/s-2003-37902. Z Gastroenterol. 2003. PMID: 12664345

9

Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon.

Herrmann E, Lee JH, Marinos G, Modi M, Zeuzem S. Herrmann E, et al. Hepatology. 2003 Jun;37(6):1351-8. doi: 10.1053/jhep.2003.50218. Hepatology. 2003. PMID: 12774014 Clinical Trial.

10

Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial.

Berg T, Kronenberger B, Hinrichsen H, Gerlach T, Buggisch P, Herrmann E, Spengler U, Goeser T, Nasser S, Wursthorn K, Pape GR, Hopf U, Zeuzem S. Berg T, et al. Among authors: herrmann e. Hepatology. 2003 Jun;37(6):1359-67. doi: 10.1053/jhep.2003.50219. Hepatology. 2003. PMID: 12774015 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

881 results

Search Page

Filters